Atgam

Atgam (Anti-T Lymphocyte Immunoglobulin) is an immunosuppressive medication used to prevent organ rejection. This horse-derived immunoglobulin is administered intravenously for therapeutic purposes.

Atgam is primarily used to prevent rejection in organ transplants, particularly kidney transplants. It works by suppressing the immune system's response to the transplanted organ. This medication is often considered when other immunosuppressive treatments have not been effective. Patients and healthcare providers may explore 'what is Atgam used for' to understand its role in transplant medicine.

Common effects of Atgam may include fever, chills, and allergic reactions during or after administration. Some patients might experience changes in blood pressure or heart rate. These effects are generally monitored by healthcare professionals during treatment.

Atgam should be administered under strict medical supervision due to its potent immunosuppressive properties. Patients with a history of severe allergic reactions to horse proteins should avoid this medication. Regular monitoring of blood counts and immune function is recommended during therapy.

Atgam may interact with other immunosuppressive drugs, increasing the risk of severe infections. It is important to inform healthcare providers about all medications being taken. Alcohol and certain over-the-counter drugs might also affect the body's response to Atgam.